Jul 9 |
What Eli Lilly Is Getting With The Acquisition Of Morphic Holding
|
Jul 9 |
Midday movers: Nvidia, Eli Lilly rise; BP, Novo Nordisk fall
|
Jul 9 |
Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.
|
Jul 9 |
Is Eli Lilly Stock a No-Brainer Buy After Its FDA Alzheimer's Disease Drug Win?
|
Jul 9 |
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss
|
Jul 9 |
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?
|
Jul 9 |
S&P 500 Closes At Record High Ahead Of Inflation Data: Fear & Greed Index Remains In 'Neutral' Zone
|
Jul 9 |
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
|
Jul 8 |
Patients Lost More Weight On Eli Lilly's Mounjaro Than Novo Nordisk's Ozempic
|
Jul 8 |
Study finds patients lost more weight on Mounjaro than Ozempic
|